Category: Prostate Cancer
-
Exercise Training May Delay PCa Progression – Renal and Urology News
PSA doubling time, a marker of cancer progression, increased from 28 to 76 months in prostate cancer patients performing exercise training. “The exercise intervention resulted in marked physiological adaptations that aided weight regulation and increased fitness levels,” Dr. Hojman told Renal & Urology News. “PSA doubling time correlated with improved fitness, but not with weight loss.…
-
Latest Dietary Advice for Prostate Cancer – Renal and Urology News
A range of foods, nutrients, and dietary patterns are being studied for prostate cancer prevention or treatment, according to a 2015 research review. Source: Latest Dietary Advice for Prostate Cancer – Renal and Urology News While the ideal diet prescription has yet to be determined, the investigators suggest counseling men with these tips, in line…
-
Study: MRI Missed 1 in 6 High-Grade Prostate Cancers
Study: MRI Missed 1 in 6 High-Grade Prostate Cancers. The much ballyhooed multiparametric (mp) MRI does not appear to be suited as stand-alone test for diagnosing prostate cancer after an elevated PSA, according to new research. The expensive and powerful technology failed to identify 16% of men with high-grade cancer (Gleason score ≥7) in a…
-
3D vs 2D laparoscopic radical prostatectomy in organ-confined prostate cancer: Comparison of operative data and pentafecta rates: A single cohort study – Abstract
3D vs 2D laparoscopic radical prostatectomy in organ-confined prostate cancer: Comparison of operative data and pentafecta rates: A single cohort study – Abstract. This study shows one surgeons experience performing laparoscopic prostatectomy with 3d vision. There are headsets that doctors can wear to overcome the 2d limitation of conventional surgery. The 3d vision improved outcomes.…
-
Statins Benefit ADT-Treated Prostate Cancer Patients | Cancer Network
Prostate cancer patients starting treatment with androgen deprivation therapy (ADT) who were already taking cholesterol-lowering statins had a 10-month prolonged time to cancer progression compared with patients who were not on statins, according to the results of a new study published in JAMA Oncology. – See more at: Statins Benefit ADT-Treated Prostate Cancer Patients |…
-
Lower PSA Predicts Favorable Salvage Radiotherapy Outcomes – Renal and Urology News
The overall median follow-up was 63.5 months. The 5-year BCR-free survival rate was 58.2% for the cohort overall and 76.2% for the 118 patients 55.7% who had early salvage RT, defined as RT started when the PSA level was 0.5 ng/mL or less, the investigators reported online in PLoS One via Lower PSA Predicts Favorable…
-
Penile Shortening After Prostate Surgery Temporary – Renal and Urology News
At six months, men who took a daily PDE5i had no SFPL loss, whereas those who did not take a PDE5i consistently had a significant mean 4.4 mm SFPL loss compared with baseline.“The present study is among the first to show preservation of SFPL in patients using daily PDE5i as compared with those patients not…
-
LUGPA position aims to clarify prostate cancer screening | Urology Times
In an attempt to clarify what it calls conflicting guideline statements on prostate cancer screening from various organizations, the Large Urology Group Practice Association (LUGPA) has issued its own position on the use of the PSA test as a screening tool. “Unfortunately, these conflicting statements have resulted in confusion amongst both our patients and fellow…